Try our Advanced Search for more refined results

Mylan Wins PTAB Review Of Pfizer's Toviaz Patents

By Matthew Guarnaccia (July 26, 2016, 2:08 PM EDT) -- The Patent Trial and Appeal Board has agreed to hear challenges by Mylan Pharmaceuticals Inc. to four patents owned by UCB Pharma GmbH relating to Pfizer Inc.'s Toviaz overactive bladder treatment, saying it is likely that they all are unpatentable....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Attached Documents

Related Sections

PTAB Case Information

Case Title

Subscribers Only

Case Number

Subscribers Only

Date Filed

Subscribers Only

Law Firms

Companies

Patents

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!